No Data
No Data
Intellia Therapeutics Price Target Cut to $70.00/Share From $80.00 by Wells Fargo
Intellia Therapeutics Is Maintained at Overweight by Wells Fargo
Intellia Therapeutics Price Target Maintained With a $14.00/Share by Wedbush
Chardan Capital Maintains Buy on Intellia Therapeutics, Raises Price Target to $91
Intellia Therapeutics Analyst Ratings
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
No Data
No Data
三和巴菲特 : Have you cried today? Baby
YWCYAPWEICHOY 叶伟财 OP 三和巴菲特 :
YWCYAPWEICHOY 叶伟财 OP 三和巴菲特 : Laughed.
71179109 : Intellia - 20% yesterday